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Background: Get4/5 is required for the efficient transfer of tail-anchored proteins to Get3.
Results: The Get3Get4/5 complex forms an intermediate mediated by electrostatic interactions.
Conclusion: The rapid association of the Get3Get4/5 intermediate complex is followed by a conformational change to the
stable inhibited structure dominated by hydrophobic interactions.
Significance: These results provide insight into the mechanism of tail-anchored protein targeting.
Tail-anchored (TA) proteins, defined as having a single trans-
membrane helix at their C terminus, are post-translationally
targeted to the endoplasmic reticulummembrane by the guided
entry of TA proteins (GET) pathway. In yeast, the handover of
TA substrates is mediated by the heterotetrameric Get4/Get5
complex (Get4/5), which tethers the co-chaperone Sgt2 to the
targeting factor, the Get3 ATPase. Binding of Get4/5 to Get3 is
critical for efficient TA targeting; however, questions remain
about the formationof theGet3Get4/5 complex.Herewe report
crystal structures of a Get3Get4/5 complex from Saccharomy-
ces cerevisiae at 2.8 and 6.0 A˚ that reveal a novel interface
betweenGet3 andGet4 dominated by electrostatic interactions.
Kinetic and mutational analyses strongly suggest that these
structures represent an on-pathway intermediate that rapidly
assembles and then rearranges to the final Get3Get4/5 com-
plex. Furthermore, we provide evidence that the Get3Get4/5
complex is dominated by a single Get4/5 heterotetramer bound
to one monomer of a Get3 dimer, uncovering an intriguing
asymmetry in the Get4/5 heterotetramer upon Get3 binding.
Ultrafast diffusion-limited electrostatically driven Get3Get4/5
association enables Get4/5 to rapidly sample and capture Get3
at different stages of the GET pathway.
The targeting ofmembrane proteins to their correct location
in the cell is a highly regulated process (1). The majority of
membrane proteins are targeted via the signal recognition par-
ticle, which typically recognizes the initial hydrophobic trans-
membrane domain as it emerges from the ribosome (2). How-
ever, the ubiquitous TA4 proteins, defined topologically by a
single transmembrane domain near the C terminus, are unable
to access the signal recognition particle pathway as their target-
ing signal, the single transmembrane domain, emerges from the
ribosome only after protein synthesis is complete and must be
targeted to the endoplasmic reticulum post-translationally (3,
4). In eukaryotes, TA proteins account for 1–2% of the pro-
teome and are involved in many essential cellular processes
such as apoptosis, vesicle fusion, and protein trafficking (5, 6).
A series of genetic and biochemical experiments in yeast and
mammalian cells identified members of a dedicated pathway
for delivery of TA proteins to the endoplasmic reticulum. In
yeast, these factors comprise the guided entry of TA proteins
(GET) pathway that consists of six proteins, Get1–5 and Sgt2,
all with homologs in higher eukaryotes (7, 8). The first commit-
ted step inTA targeting is the formation of an Sgt2TAcomplex
(9), whichmay be assisted by chaperones. TA substrate is trans-
ferred to Get3 in a Get4/5-dependent manner (9). Extensive
structural characterization of Get3, the central TA targeting
factor, demonstrated that it undergoesATP-dependent confor-
mational changes from an open to closed form required for
capturing the TA substrate (10–15). Once formed, this
Get3TA complex is then localized to the endoplasmic reticu-
lum by themembrane proteins Get1 andGet2, which stimulate
release of the TA protein and subsequent insertion into the
endoplasmic reticulum membrane (16–19).
Efficient delivery of a TA substrate to Get3 requires the het-
erotetrameric Get4/5 that provides the link between Sgt2 and
Get3 (9, 20, 21). Get4/5 stabilizes the ATP-bound state of Get3,
delaying ATP release and inhibiting ATP hydrolysis, thereby
locking Get3 in a conformation competent for TA substrate
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binding (22). Recently, the first crystal structure of a Get3
Get4/5 complex provided insight into the role of nucleotide in
complex formation where Get4 binds to two functionally dis-
tinct binding interfaces that govern anchoring andATPase reg-
ulation on a closed Get3 (23). Importantly, mutations intro-
duced at these interfaces demonstrated that Get4-mediated
regulation of ATP hydrolysis by Get3 were critical for efficient
TA targeting. A recent study has now shown that Get4/5 bind-
ing to Get3 occurs on rapid diffusion-limited time scales, sug-
gesting an electrostatic interaction (24). However, the nature of
this interaction cannot be explained by the aforementioned
Get3Get4/5 structure.
This report describes the crystal structure of a Get3Get4/5
intermediate complex from Saccharomyces cerevisiae in two
crystal forms, at 2.8 and 6.0 Å, respectively. The structure rep-
resents an initial binding interactionmediated by electrostatics
that facilitates the rate of subsequent complex formation. This
is supported by kinetic analysis of Get3Get4/5 complex forma-
tion that provides direct evidence for the two-step complex
formation mechanism. Finally, mass spectrometry and multi-
angle light scattering were used to demonstrate that, under
physiological steady-state conditions, a single Get4/5 heterote-
tramer is bound to one monomer of a Get3 dimer. This work
allowed us to generate a refined model for Get3Get4/5 com-
plex formation.
Experimental Procedures
Protein Cloning, Expression, and Purification—The se-
quences of Get4 and Get5 were cloned as described previously
(25). To generate the Get4/5N used in this study, this construct
was furthermodified by truncating theC terminus of Get4 (res-
idues 291–312) and by the addition of a stop codon after residue
54 within Get5 and verified by DNA sequencing. All Get4/5
proteins were overexpressed in BL21-Gold(DE3) (Novagen)
grown in 2YT (16 g/liter tryptone, 10 g/liter yeast extract, and
5 g/liter NaCl) medium at 37 °C and induced for 3 h by the
addition of 0.5 mM isopropyl -D-1-thiogalactopyranoside.
Cells were lysed using a Microfluidizer (Microfluidics) and
purified as a complex by nickel affinity chromatography (Qia-
gen). The affinity tagwas removed by an overnight tobacco etch
virus protease digest at room temperature while dialyzing
against 20 mM Tris, pH 7.5, 30 mM NaCl, and 5 mM -mercap-
toethanol (BME). A second nickel-nitrilotriacetic acid column
was used to remove any remainingHis-tagged protein, and then
the sample was loaded onto a 6-ml Resource Q anion exchange
column (GE Healthcare). The peak containing the Get4/5N
complex was collected and concentrated to 15–20 mg/ml. Ini-
tial purifications of the Get4/5N complex were verified to be a
single monodispersed species by size exclusion chromatogra-
phy (SEC) using a Superdex 200 16/60 column (GEHealthcare)
equilibrated with 20 mM Tris, pH 7.5, 100 mM NaCl, and 5 mM
BME. Full-length Get4/5 used in biochemical studies was fur-
ther purified using a Superdex 200 16/60 column (GE Health-
care) equilibrated with GET buffer (50 mM K-HEPES, pH 7.5,
150mMKOAc, 10mMMg(OAc)2, 10% (v/v) glycerol, and 5mM
BME). Fractions containing Get4/5 were pooled and concen-
trated to5 mg/ml.
The S. cerevisiaeGet3 coding region was cloned as described
previously (10). A His6 tag followed by a tobacco etch virus
protease site was fused to theN terminus, and a stop codonwas
placed in front of the C-terminal His6 tag. All S. cerevisiaeGet3
mutants were generated using the QuikChange method. All
Get3 proteins were expressed in BL21-Gold(DE3), grown in 2
YT (16 g/liter tryptone, 10 g/liter yeast extract, 5 g/liter NaCl)
medium, and induced with 0.5 mM isopropyl -D-1-thiogalac-
topyranoside for 16 h at 22 °C. Cells were lysed using a Micro-
fluidizer and purified by nickel affinity chromatography. The
affinity tag was removed by an overnight tobacco etch virus
protease digest at room temperature while dialyzing against 20
mM Tris, pH 7.5, 100 mM NaCl, and 5 mM BME. A second
nickel-nitrilotriacetic acid column was used to remove any
remaining His-tagged protein, and then the sample was run on
a Superdex 200 16/60 column (GE Healthcare) equilibrated
with dialysis buffer (crystallization trials) or GET buffer (bio-
chemical studies). Fractions corresponding to a dimer of Get3
were pooled and concentrated to 15–20 mg/ml.
Get3Get4/5N complex was formed by equilibrating 105
mol of Get4/5N with 100 mol of Get3 at room temperature
in 500 l of 20 mM Tris, pH 7.5, 10 mMNaCl, 5 mM BME, 1 mM
MgCl2, and either 1 mM ADP, AMP-PNP, or ATP. Prior to
complex formation, Get3 had been pre-equilibrated with 1 mM
MgCl2 and either 1 mM ADP or 1 mM AMP-PNP for 5 min at
room temperature. Get3Get4/5N complex was further sepa-
rated from free Get4/5N using Superdex 200 10/300 (GE
Healthcare) equilibrated with 20mMTris, pH 7.5, 10 mMNaCl,
and 5 mM BME. Get3Get4/5N complex using full-length Get4
was formed as above but in the absence of nucleotide and
MgCl2. This complex was further separated from free Get4/5N
using Superdex 200 16/60 (GEHealthcare) equilibratedwith 20
mM Tris, pH 7.5, 10 mM NaCl, and 5 mM BME. All complexes
were concentrated to 10–12mg/ml before use in crystallization
experiments.
Crystallization—Get3Get4/5N crystal trials were carried out
using the sitting drop vapor diffusion method at room temper-
ature by equilibrating equal volumes of the protein complex
solution and reservoir solution using a TTP LabTechMosquito
robot and commercially purchased kits (Hampton Research,
Qiagen, and Molecular Dimensions Ltd.). The 2.8-Å Get3
Get4/5N intermediate complex crystals grew in the presence of
17% PEG 3350, 0.24 M sodium citrate, and 30 mM tris(2-car-
boxyethyl)phosphine. Crystals were cryoprotected by transfer-
ring directly to 10 l of a reservoir solution supplemented with
20% glycerol, 1 mM ADP or AMP-PNP, and 1 mM MgCl2 and
incubated for10min before being flash frozen in liquid nitro-
gen. The 6.0-Å Get3Get4/5N intermediate complex crystals
grew in the presence of 12% PEG 3350 and 0.1 M sodiummalo-
nate, pH 5.0, and were cryoprotected by transferring directly to
10 l of a reservoir solution supplemented with 20% glycerol
before being flash frozen in liquid nitrogen.
Data Collection, Structure Solution, and Refinement—All
structures were solved using data sets collected on Beamline
12-2 at the Stanford Synchrotron Radiation Lightsource. Each
structure was solved from a single data set that was integrated
using MOSFLM (26) or XDS (27) and scaled and merged using
SCALA (28, 29). The crystal of Get3Get4/5N in the intermedi-
The Get3Get4/Get5 Intermediate Complex
DECEMBER 11, 2015•VOLUME 290•NUMBER 50 JOURNAL OF BIOLOGICAL CHEMISTRY 30007
 at CA
LIFO
RN
IA
 IN
STITU
TE O
F TECH
N
O
LO
G
Y
 on D
ecem
ber 16, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ate conformation diffracted to 2.8 Å, and phases were obtained
by molecular replacement with Phaser (30) as implemented in
PHENIX (31) using a monomer of the open (apo) form of Get3
(Protein Data Bank code 3A37) and one Get4/5N heterodimer
(Protein Data Bank code 3LKU) as search models. Coordinates
were refined using REFMAC v6.3 (28, 29) with NCS and B-fac-
tor restraints. Manual rebuilding was performed using Coot
(32). Translation/libration/screw groups were included in the
later refinement stages and were determined using the TLSMD
web server (33). These associated regions within the structure
were allowed a certain degree of variation based on predicted
motions they might have during data collection. The final
model refined to an R-factor of 22.4% (Rfree 26.1%). The sec-
ond structure in the intermediate conformation was solved to
6.0 Å using methods similar to those described above. This
structure lacked theGet4C-terminal truncation engineered for
the other structures and refined to an R-factor of 27.4% (Rfree
30.3%). Full crystallographic statistics are in Table 1.
Structure Analysis and Figures—Schematic representa-
tions of protein structures were prepared using PyMOL
(Schro¨dinger, LLC), whereas surface representations were pre-
pared using UCSF Chimera (34). Surface figures were made in
Chimera. Electrostatic surface potentials were calculated using
Adaptive Poisson-Boltzmann Solver with default values as
implemented in the PDB2PQR web server (35, 36).
Isothermal Titration Calorimetry—Get3Get4/5N binding
experiments were carried out using the MicroCal iTC200 sys-
tem (GE Healthcare). Binding affinities were measured by
titrating 350 M Get4/5N into a sample cell containing 50 M
Get3 D57V. All samples were diluted in GET buffer containing
1 mM ATP. For the first titration, 0.4 l of Get4/5N was
injected. For all following titrations, 2 l of Get4/5N was
injected for 20 intervals spaced 120 s apart at 25 °C. The stirring
speed and reference powerwere 1000 rpmand 5cal/s. Affinity
constants were calculated from the raw data using Origin v7.4
software (MicroCal).
Multiangle Light Scattering—100l of 35MGet3 and 100l
of 35 MGet4/5 were prepared in GET buffer containing 1 mM
ATP and either loaded separately or together onto a Superdex
200 10/300 (GE Healthcare) column equilibrated in GET
buffer. Samples were analyzed using a Dawn HELEOS II multi-
angle light scattering unit (Wyatt Technology).
Alkylation and Mass Spectrometry—Get4/5 S48C/C177T
was reduced with 2.5 mM tris(2-carboxyethyl)phosphine in
GET buffer (without reducing agent) at room temperature for
2 h. For each alkylation reaction, 1 M Get4/5 alone or in the
presence of 2 M Get3 was preincubated in 2 mM ATP for 10
min to allow for complex formation followed by the addition of
30 M N-ethylmaleimide. The reaction was quenched with 9.0
mMDTT at the indicated time points, concentrated under vac-
uum, and redissolved in 0.2% formic acid, and 50 pmol of pro-
tein was analyzed on an LC-MSD SL 1100 series (Agilent) mass
spectrometer. The samples were chromatographed on a 2.1 
150-mm Zorbax 300SB-C3 column (Agilent) using a gradient
consisting of 0.2% formic acid and 0.2% formic acid in 89.8%
acetonitrile and 10% methanol. The m/z values of the intact
proteins were measured in the single quadrupole, deconvo-
luted, and quantified using theChemStation software (Agilent).
Control experiments in which different ratios of unalkylated
and alkylated proteins weremixed and subjected toMS analysis
showed the quantification of the ratio of alkylated species to be
reliable (37).
Get4/5 PEGylation Assay—Get4/5 Q34C/C177T containing
a His6 tag was reduced with 2.5 mM tris(2-carboxyethyl)phos-
phine in GET buffer (without reducing agent) at room temper-
ature for 2 h. For each PEGylation reaction, 0.45 M Get4/5
alone or in the presence of 2MGet3was preincubated in 2mM
ATP for 10 min to allow complex formation followed by
the addition of 60 M PEG maleimide (10-kDa conjugates;
Sigma). The reaction was quenched with 9.0 mM DTT at the
indicated time points, and the extent of Get4/5 PEGylation was
followed by Western blotting with an anti-His antibody (Qia-
gen). The ratio of unmodified Get4/5 to PEGylated Get4/5 was
determined using ImageQuant software (GE Healthcare).
Fluorescent Labeling—Following purification over an UnoQ
column (GE Healthcare), Get4/5 S48C/C177T and Get4/5N
S48C/C177T were labeled with thiol-reactive acrylodan. Pro-
tein was dialyzed in labeling buffer (50 mM K-HEPES, pH 7.0,
and 300 mM NaCl) and treated with 2 mM tris(2-carboxyethyl)
phosphine to reduce the disulfide bonds. The labeling reaction
was carried out using a 10–30-fold excess of dye over protein.
The reaction was incubated overnight at 4 °C and stopped by
adding 2 mM DTT. Excess dye was removed by gel filtration
using Sephadex G-25 (Sigma) equilibrated with GET buffer.
Association and Dissociation Rate Measurements—All rate
measurements were performed on a KinTek Corp. stopped-
flow apparatus using sample prepared in GET buffer. For asso-
ciation rate measurements, acrylodan-labeled Get4/5 was held
constant at 0.2M, Get3 concentration was varied as indicated,
and ATP was present at 2 mM. Observed rate constants (kobsd)
TABLE 1
Summary of crystallographic data
r.m.s.d., root mean square deviation.
Intermediate complex
2.8 Å 6.0 Å
Data set
Wavelength (Å) 1.0000 0.9795
Resolution range (Å) 29.8–2.8 (2.9–2.8)a 30.0–6.0 (6.6–6.0)
Space group P 21212 P 21
Cell parameters
a, b, c (Å) 112.0, 238.0, 52.2 152.4, 127.3, 210.3
, ,  (°) 90, 90, 90 90, 110.2, 90
Unique reflections 34,114 (4,406) 18,388 (4,452)
Completeness (%) 97.0 (95.7) 96.3 (98.7)
Redundancy 3.3 (3.1) 3.2 (3.4)
Rsymb 0.06 (0.58) 0.06 (0.78)
Mean I/(I) 8.3 (1.6) 8.9 (1.4)
Refinement
Reflections: work/free 32,332/1,710 17,462/917
Rwork/Rfree 0.224/0.261 0.274/0.303
No. protein atoms 7,750 41,984
No. ligand atoms 1 4
Protein B-factors (Å2) 111.0 361.8
Water/ligand B-factors (Å2) 111.1 357.5
r.m.s.d. of bond lengths (Å) 0.0148 0.0031
r.m.s.d. of bond angles (°) 1.70 0.74
Ramachandran preferred (%) 96.0 91.0
Ramachandran allowed (%) 3.3 6.7
Ramachandran outliers (%) 0.7 2.3
a Values in parentheses are for the highest resolution shell.
b Rsym hkliIi(hkl)I(hkl)	/hkliIi(hkl) where Ii(hkl) is ith observation
of reflection hkl and I(hkl) is the weighted average intensity for all observations i
of reflection hkl.
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were plotted as a function of Get3 concentration and fit to the
following equation (Equation 1).
kobsd kon
Get3	 koff (Eq. 1)
in which kon is the association rate constant and koff is the dis-
sociation rate constant.
For dissociation rate measurements, a pulse-chase experi-
ment was used. A complex between acrylodan-labeled Get4/5
(at 0.15 M) and Get3 (at 0.3 M) was preformed by incubation
in 2 mM ATP for 10 min followed by addition of unlabeled
Get4/5 at 6M as the chase to initiateGet3Get4/5 dissociation.
The time course for change in fluorescence (Fobsd) was fit to the
following double exponential function (Equation 2).
Fobsd  Fe	 F1
 e
 kfastt 	 F2
 e
 kslowt (Eq. 2)
in which Fe is the fluorescence when the reaction reaches equi-
librium, F1 and kfast are the magnitude and rate constant of
the fluorescence change in the fast phase, andF2 and kslow are
the magnitude and rate constant of the fluorescence change
in the slow phase.
KineticModeling—The kinetic model was derived using Kin-
Tek Explorer Professional Software (KinTek Corp.) (38, 39).
Kinetic and equilibrium simulations were carried out using the
rate constants listed in Fig. 1H, and values for the experimental
data were taken from Rome et al. (24).
Kinetic Simulations—Simulation of Get3Get4/5 association
was carried out using theKinTek Explorer association function.
Equations used to model the associations are listed in Table 2
where G3 denotes Get3, G45 denotes fluorescently labeled
Get4/5, Get345 denotes the intermediate Get3Get4/5 com-
plex, G345* denotes the inhibited Get3Get4/5 complex after
rearrangement, and G345*G45 denotes the saturated complex
with two Get4/5 bound to the Get3 dimer (refer to Fig. 1H).
Modeling used the following initial conditions: [G45]0  0.2
M, [G3]0 0.1, 0.18, and 0.26 M. The following fluorescence
values (F in arbitrary units) were assigned to each species: F 5
for G45, F  10 for G345 and G345*, F  20 for G345*45. For
the equation G345NG345*, the forward and reverse rate con-
stants were varied until the simulation results matched experi-
mental data.
Simulation of the dissociation kinetics of the Get3Get4/5
complexes was carried out using the KinTek Explorer two-step
mixing function, which accurately reflects the experimental
pulse-chase setup. In the first time period (T1), 0.3 M G3 and
0.15 M G45 were mixed for 3 s allowing for equilibrium to be
reached. During the second time period (T2), 6 M unlabeled
Get4/5 (chase; designated C) was added to this mixture. Disso-
ciation of the Get3Get4/5 complexes during T2 involves a col-
lection of exchange reactions betweenG45 and the chase (unla-
beled Get4/5) represented by equations in Table 3.
To simulate the equilibrium of complex formation between
Get3 and Get4/5, the KinTek Explorer equilibrium titration
functionwas used. For these simulations, 0.05MG45was held
constant, and the fluorescence at equilibrium was simulated
with increments of 0.005 M G3 until a final concentration of
0.5 M G3 was reached.
Results and Discussion
Formation of the Get3Get4/5 Complex Follows an Electro-
statically Driven Intermediate—To understand themechanism
of assembly for the Get3Get4/5 complex, we characterized the
assembly pathway using pre-steady-state kinetics. Complex
formation was monitored using acrylodan-labeled Get4/5
whose fluorescence is enhanced upon binding Get3 (24). The
Get3Get4/5 complex has been demonstrated to be highly sta-
ble but dynamic, and its formation follows rapid biphasic asso-
ciation at near diffusion-limited time scales (24). The observed
association rate constants in both kinetic phases are linearly
dependent on Get3 concentration (24), indicating that both
phases represent bimolecular association of Get3 with Get4/5.
Although the initial report used full-length Get4/5, the same
biphasic association was observed with a truncated Get4/5N
that lacks the homodimerization domain of Get5 and hence
forms a heterodimer (Fig. 1,A andB) (23, 25). This rules out the
possibility that the second kinetic phase arises from binding of
Get3 to the second Get4 molecule in a Get4/5 heterotetramer.
Additional characterizations strongly suggest the presence of
an additional rearrangement step in the assembly pathway.
First, the rate of the initial “burst” phase is strongly dependent
on ionic strength, consistent with an electrostatically driven
association (Fig. 1C) (24), whereas the second association phase
is independent of ionic strength (Fig. 1D) (24). This suggests a
structural rearrangement to adopt amore stable interface prior
to the second association phase. Second, despite the large
changes in the relative association rates of the salt-sensitive and
-insensitive phases, the amplitudes of these two phases are
unaltered by changes in ionic strength (Fig. 1E). This argues
against the possibility that the biphasic association arises from
parallel pathways, i.e. that the second association phase arises
from a subpopulation of Get3 (or Get4/5) that binds the inter-
action partner with slower kinetics. Third, the dissociation rate
constant extrapolated from the fast association phase (Fig. 1B)
is 8–10 s1 (kobsd kon[Get3] koff); this koff value is 10–100-
fold faster than those of the final Get3Get4/5 complex deter-
mined directly in pulse-chase experiments (Fig. 1F) (24), sug-
gesting that the initial association gives rise to an unstable
TABLE 2
Equations used to model Get3Get4/5 association kinetics
Equation kfor krev
M1 s1 s1
G3 G45N G345 144 8
G345N G345* Varied Varied
G345* G45N G345*G45 43.5 0.09
TABLE 3
Equations used to model Get3Get4/5 dissociation kinetics
Equation kfor krev
M1 s1 s1
G3 CN G3C 144 8
G345 CN G345C 144 8
G345* CN G345*C 43.5 0.09
G45 G3CN G345C 144 8
G45 G3C*N G345*C 43.5 0.09
C G3C*N G3C*C 43.5 0.09
G345CN G345*C 12 1
G3C CN G3CC 144 8
G3CN G3C* 12 1
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FIGURE 1.Get4/5 undergoes a conformational change upon bindingGet3. A, time course of Get4/5N binding to ATP-bound Get3. Arrows indicate the two
kinetic phases. B, observed rate constants during binding (kobsd) are analyzed as a function of Get3 concentration to determine the association rate constant
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intermediate that must subsequently rearrange to adopt more
stable interfaces. Further in support of this model are results
from the dissociation rate measurements. Although dissocia-
tion of the Get3Get4/5 complex also exhibits biphasic kinetics,
neither the rates nor the magnitude of the phases is dependent
on ionic strength (Fig. 1F). Finally, the magnitude of the slow
dissociation phase increases successively when apo-Get3 is
compared with ADP- and ATP-bound Get3 (Fig. 1G), consis-
tent with previous data showing that ATP strengthens binding
between Get3 and Get4/5 by inducing Get3 into a more closed
conformation (22–25, 31).
These new data, coupled with kinetic simulation, support a
multistep mechanism for the Get3Get4/5 interaction as the
simplest model to explain all the available observations (Fig.
1H) (24). In this model, association of Get3 with Get4/5
involves the following steps. (i) Resting Get3 bound to ATP is
biased toward a “closed” conformation. (ii) Initial binding of
Get4/5 to Get3 is rapid and generates an intermediate domi-
nated by electrostatic interactions. (iii) This is followed by a
conformational change to the final stable structure dominated
by hydrophobic interactions. (iv) Under the experimental con-
ditions, the second subunit in the Get3 dimer can bind another
Get4/5 to give rise to the second phase in association kinetics.
Using the experimentally observed kon and koff values fromboth
the salt-sensitive and salt-insensitive phases, the equilibrium
binding data, and kinetic modeling, we were able to completely
assign the rate constant for individual microscopic steps in this
model. Analytical simulations based on this model reproduced
the experimentally observed association/dissociation kinetics
and equilibrium titrations (Fig. 2A). Furthermore, the equilib-
rium titration data with full-lengthGet4/5 (24) could only be fit
to a 1:2 stoichiometry in which a Get3 dimer is bound to two
different Get4/5 heterotetramers (Fig. 2B), consistent with the
biphasic nature of complex formation.
Although binding of a second Get4/5 to Get3 was observed
(Fig. 1H), multiple observations suggest that the stable inhib-
ited Get3Get4/5 complex (species iii) dominates under most
conditions, and accumulation of the saturated Get3Get4/5
complex (species iv) is modest. First, previous assays of Get3
activity show that binding of one full-lengthGet4/5 is sufficient
to inhibit the ATPase activity of Get3 (22). Second, kinetic sim-
ulations showthatduringcomplexassemblywith relatively stoi-
chiometric amounts of proteins the saturated Get3Get4/5
complex accumulates to 20% of all the complexes formed
(Fig. 2C). Coupled with the different Get3Get4/5N complexes
in various crystal structures (23), it appears that binding
of Get4/5 to Get3 has a preferred but not obligatory
stoichiometry.
The Structure of a Get3Get4/5 Intermediate Complex—The
recent crystal structure of an ATP-bound Get3Get4/5N com-
plex demonstrated a stable interface that included conserved
hydrophobic interactions (23). The structure allowed rational-
ization of howGet4 stabilized an ATP-bound Get3; however, it
was unclear how the structure could account for the multistep
Get3Get4/5 assembly seen experimentally. To address this
question, we set out to obtain a structure of Get4/5N bound to
a Get3 dimer under conditions that would stabilize an initial
intermediate complex. As before (23), Get3 and Get4/5 were
expressed and purified separately, then combined, and purified
as a 1:1 complex in low ionic strength conditions by SEC (23).
Initial crystals were obtained using aGet4/5N construct similar
to that used for solving the structure of the Get4/5N het-
erodimer (25). This resulted in a crystal that diffracted to 6.0 Å
in space group P21. Phases for this crystal form were obtained
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by molecular replacement using an “open” form of Get3 (Pro-
tein Data Bank code 3A37) (14) and the Get4/5N heterodimer
(Protein Data Bank code 3LKU) as search models. The final
model was refined to an R/Rfree of 27.4/30.3% (Table 1). To
improve the diffraction limit, purification and crystallization
trials were performed in the presence of either ADP or the
non-hydrolyzable ATP analogue AMP-PNP. In addition, 22
residues from theC terminus ofGet4were truncated as they are
disordered in previous structures (12, 25). This resulted in a
new crystal form that diffracted to 2.8 Å in space group P21212.
The final model was refined to an R/Rfree of 22.4/26.1% (Table
1). Although ADP and AMP-PNP produced identical crystal
forms, the highest resolution data set reported here was col-
lected from a crystal that grew in the presence of AMP-PNP,
although the nucleotide was not visible in the density.
The Get3Get4/5 Intermediate Complex Is Dominated by an
Electrostatic Interface—In both crystal forms, Get4 binds in a
similar orientation on Get3 (Fig. 3, A and B). The 2.8-Å struc-
ture contains a 2:1 complex of a Get3 dimer bound to a single
Get4/5N heterodimer (Fig. 3A). This crystal form is related to
another Get3 crystal form (14) in which limited space in the
crystal lattice allows for only one Get4/5Nmolecule despite the
1:1 stoichiometry of the complex put into crystallization trays
(as measured by SEC). Although nucleotide was present
throughout purification and crystallization, the nucleotide-
binding pocket appears empty. For the 6.0-Å structure (Fig. 3B),
the asymmetric unit contained a 1:1 complex with eight copies
of Get3 bound to eight Get4/5N heterodimers (Fig. 3B, top
right).
In both cases, Get3 is in an open conformation, and Get4/5N
binds in the same interface and orientation, defined here as the
intermediate complex. Despite the differences in crystallization
and space group, there is little difference in the interface
between the two structures, only a slight 10° rotation at the
furthest point (Fig. 3C). The higher resolution structure will
be used for reference for the rest of the text. In this intermediate
complex, Get4 interacts with a single monomer of Get3 in an
orientation compatible with both the open and closed struc-
tures, burying 970 Å2 of surface area (Figs. 3D and 4A). The
interactions in this interface are electrostatic and involve the
positively charged surface of Get4 binding to the negatively
charged surface of Get3 (Fig. 4, A and B).
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FIGURE3.Crystal structuresofaGet3/4/5 intermediatecomplex.A, theasymmetricunit of the2.8-Å structureofGet4/5N (Get4,green; Get5N,gray) bound toGet3
(wheat andmagenta). B, left, one subunit from the 6.0-Å structure containing twoGet4/5Nmolecules (Get4, salmon; Get5N, gray) bound to a Get3 dimer (wheat and
magenta).Topright, theasymmetricunitof the6.0-ÅstructureofGet4/5N(Get4, red;Get5N,gray)boundtoGet3 (wheatandmagenta). TheblackboxoutlinesoneGet3
dimer(wheatandmagenta)boundtotwoGet4/5Nheterodimers (Get4,salmon;Get5N,gray).Therestoftheasymmetricunit iscoloredasfollows:Get3, lightgray;Get4,
dark gray; Get5N, black. C, two views showing the relative orientation of Get4monomers from the 2.8- (green) and 6.0-Å (red) crystal forms. Alignmentwas based on
helices10and11 fromthecontactingGet3monomer.D, viewof the interface fromthe2.8-Åstructure showing interactionsbetweenGet4 (green) andGet3 (wheat
andpurple). ResiduesAsp263 (red) andGlu307 (blue)were tested for interactionandcoloredbasedonphenotype.These residuesareuniquetothis interfaceandarenot
found in the ATP-bound structure (23).Dashed lines represent potential interactions and are labeledwith their atomic distances.
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In this orientation, Get4 1 sits on top of a groove formed by
the loop before Get3 1 and the loop following Get3 11 such
that the N terminus of Get4 1 packs against the loops follow-
ing Get3 9 and 10, resulting in an interaction between Lys23
on Get4 1 and Glu307 on Get3 (Fig. 3D). In addition, Get4 2
packs roughly perpendicularly to Get3 10 and 11 such that
the N terminus contacts Get3 11 and the C terminus contacts
Get3 10. This results in interactions of the invariant residues
Arg42 on Get4 2 with Asp308 on Get3 and Arg45 on Get4 2
with both Glu253 and Gln257 on Get3 10 (Fig. 3D). The N
terminus of Get4 3, which is oriented between 1 and 2,
contacts the top of Get3 10, allowing His51 on Get4 3 to
interact with Asp263 on Get3 10 (Fig. 3D).
Comparison of the Two Distinct Get3Get4/5 Complexes—In
the previously reported ATP-bound Get3Get4/5N complex,
Get4/5N is bound across the dimer interface of a closed Get3,
forming interactions with both monomers, which we define as
the inhibited complex (Fig. 4C). This is in contrast to the cur-
rent structure, which is bound to an open Get3 and interacts
with only one monomer (Fig. 4C). Because the Get4-binding
surfaces do not undergo a significant conformational change
between the open and closed Get3 structures, we aligned the
helices (10 and 11) involved in Get4 binding from our inter-
mediate complex onto the inhibited complex. Both structures
have overlapping binding sites and predominantly utilize the N
terminus of Get4 for the interaction (Fig. 4B). The difference in
orientation involves a rotation centered on 2 of Get4. This
rotation allows Get4 2 to form themajority of the interactions
in the inhibited complex, whereas Get4 1 is responsible for
many interactions in the intermediate complex. Based on the
multistep assembly observed from kinetic analysis, we believe
that the new structure dominated by electrostatics represents
the intermediateGet3Get4/5 complex (Fig. 1H, species ii) prior
to rearrangement to the final structure stabilized by hydropho-
bic interactions.
Mutational Analysis of the Intermediate Complex—The
intermediate complex interface involves numerous electro-
static residues on both Get3 and Get4. Of these interactions,
only Get3 Asp263-Get4 His51 and Get3 Glu307-Get4 Lys23 are
unique to the intermediate interface and are not found in the
inhibited complex (Fig. 5A). The first interaction (Asp263-
His51) is not conserved; however, in higher eukaryotes, there is
conservation of a likely salt bridge (Fig. 5A). The conserved
Get3 Glu307 also interacts with the cytoplasmic domain of Get2
(16, 17), whereas Get4 Lys23 is not conserved (Fig. 5A). Substi-
tution of Get3 Asp263 leads to a loss of observable binding to
Get4/5N in isothermal titration calorimetry measurements
(Fig. 5, B and C), whereas substitution of Get3 Glu307 had a
more modest loss in affinity (Fig. 5, B and C).
If the intermediate complex is on-pathway to the final
Get3Get4/5 complex, one would predict that disrupting the
interactions unique to this intermediate would slow down
Get3Get4/5 association. Disrupting the putative Get3 Glu307-
Get4 Lys23 interaction (E307A) resulted in similar association
rates compared with wild type Get3 and, together with the iso-
thermal titration calorimetry results, suggests that the interac-
tion is not essential for complex formation (Fig. 5, B–D). In
contrast, significantly reduced rates of Get3Get4/5 association
were observed with Get3 D263A (Fig. 5, B–D). Although the
association rates are slightly higher than previously reported,
the differences are small (2-fold) and do not change the inter-
pretation. Both mutants had virtually identical dissociation
rates comparedwith wild typeGet3; therefore, the difference in
affinity for D263A is specific for complex formation kinetics
(Fig. 5, B–D).
If Get3 D263A follows the same assembly pathway as wild
type Get3, one would expect that once the Get3 D263AGet4/5
complex is formed it has the same equilibrium stability as the
wild type complex because Asp263 does not participate in inter-
face interactions in the final complex (Fig. 5E). However, the
weakened equilibrium stability of theGet3D263AGet4/5 com-
plex indicates that the changes induced by D263A are more
complex, and this mutant likely follows a different assembly
pathway leading to a non-native complex. Because a reaction
follows the fastest pathway, this observation in turn suggests
that the D263A mutation slows the native assembly pathway
more extensively than was experimentally measured. Collec-
tively, mutational analysis of the intermediate complex pro-
-12 12
kT/e
Get3
Get4
A
B
90o
C InhibitedComplex
Intermediate
Complex
FIGURE 4. Comparing the intermediate and inhibited interfaces. A, left, orientation of Get3 used in subsequent panels to highlight binding interface. For
surface representations, one monomer is outlined in black, and the interaction surface of Get4 on Get3 is highlighted by dashed lines for encounter complex
(green) and inhibited complex (blue). Right, accessible surface color-ramped based on electrostatic potential from 12 (red) to 12 kT/e (blue). B, surface
properties of Get4 as in A except that Get4 is color-ramped from the N terminus (blue) to the C terminus (red), and Get5N is colored gray. C, two views of the
overlayofGet4 fromthe intermediate complex (green) and inhibited complex (blue) on the closedGet3dimer fromProteinDataBank code4PWX (23). TheGet4
from the intermediate complex was orientated by aligning helices 10 and 11 on one monomer of Get3.
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vides independent evidence that the structure observed here
represents an on-pathway intermediate during Get3Get4/5
assembly.
Stoichiometry between Get3 and Get4/5—The stoichiometry
of the Get3Get4/5 interaction is not fully determined. A recent
SEC-multiangle light scattering analysis using an ATPase-defi-
cient Get3 (D57N) suggested that the complex contains one
Get4/5 heterotetramer bound to one Get3 dimer (40). Using
wild type Get3, SEC-multiangle light scattering analysis with
equimolar concentrations of Get3 and Get4/5 confirmed that
the size of the complex is consistent with a single Get4/5 het-
erotetramer bound to a single Get3 dimer (Fig. 6A) (23).
One puzzling observation arises from these data: despite the
presence of twoGet4molecules in full-length Get4/5, there has
been no evidence for binding of Get3 to the second Get4 in the
Get4/5 heterotetramer. To directly test this asymmetry of
Get4/5 during complex formation, we developed an alkylation
protection assay. An engineered cysteine at the Get3Get4/5
interface (Get4 S48C (24)) is allowed to react with N-ethylma-
leimide in the absence and presence of various factors (Fig. 6B).
In the free Get4/5, Get4 Cys48 is solvent-exposed (25) and rap-
idly alkylates to completion (Fig. 6, B and C). Consistent with
binding at a single Get4 interface, only 50% of Get4 Cys48 was
protected from alkylation by Get3 (Fig. 6C). This protection
pattern was observed at Get3 concentrations nearly 1000-fold
above the dissociation constant for the Get3Get4/5 complex,
indicating that the 50% protection did not arise from incom-
plete Get3Get4/5 binding. These results strongly suggest that
only one site of a Get4/5 heterotetramer is able to bind Get3.
To further support these results, accessibility of Get4/5 was
probed using a 10-kDa PEG maleimide. A second site (Get4
Q34C) that is also occluded in theGet3Get4/5N structure (Fig.
6D) was chosen to further validate the interface. Importantly,
substitution ofGln34 to alanine does not impair binding toGet3
(23). In this reaction, Get4 Q34C with PEG maleimide forms a
covalent adduct that gives a 10-kDa increase inmass that can be
detected by SDS-PAGE andCoomassie staining. In the absence
of Get3, this reaction resulted in 100% PEGylation of Get4/5
over a 2-min time course, whereas addition of saturating Get3
resulted in 50% PEGylation (Fig. 6E). This provides corroborat-
ing evidence that only one Get4 molecule in a heterotetramer
binds Get3. Together, these data indicate that once Get3 binds
to Get4/5 the other Get4 molecule in the Get4/5 heterote-
tramer is inhibited from further interaction with another Get3
dimer.
AModel forGet3Get4/5Complex Formation—Multiple lines
of evidence support a model in which Get3 and Get4/5 rapidly
form an electrostatic intermediate complex and then undergo a
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FIGURE 5.Get3D263A is defective for complex formation.A, sequence alignments of regions involved in contacts in theGet3-Get4 interface usingClustalW
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labeled. Highlighted residues are unique to the intermediate interface and were tested for binding: red, S. cerevisiae Get3 Asp263 and S. cerevisiae Get4 His51;
blue, S. cerevisiaeGet3 Glu307 and S. cerevisiaeGet4 Lys23. B, summary of the data obtained from isothermal titration calorimetry (ITC) and kinetic experiments.
C, representative isotherms from ITC experiments.D, top, representative association ratemeasurements of Get4/5 binding towild type andmutantGet3 at 260
nM. Each plot represents the average of 10 experiments. Bottom, representative dissociation rate measurements with wild type and mutant Get3. Each plot
represents the average of three experiments. E, free energy diagram of the effects of the Get3 D263A mutation on Get3Get4/5 complex formation. A.U.,
absorbance units.
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structural rearrangement to a more stable complex (24) (Fig.
2A). This conformational change is consistent with previous
results showing that Get4/5 binding induces Get3 into an
“occluded” state, leading to Get3 ATPase inhibition and
delayed ATP dissociation kinetics (22). Based on this model,
onceGet3 has transitioned to the occluded conformation, com-
plex dissociation would be insensitive to buffer ionic strength
(Fig. 1F) but dependent on nucleotide (Fig. 1G).
The initial Get3Get4/5 complex presented here (Fig. 3, A
and B) reveals a novel binding interface composed of electro-
static interactions (Fig. 3D). This structure provides themolec-
ular basis for the initial salt-dependent association seen in our
kinetic description of the Get3Get4/5 interaction (Fig. 1).
Although Get3 is in an open conformation, these structures
likely represent the true on-pathway intermediate because the
Get3-Get4 interface does not change between the open and
closed forms. This is corroborated by the D263A mutation
introduced within this interface that drastically slows down
complex formation (Fig. 5). These data coupledwith the kinetic
experiments argue that these structures represent the initial
intermediate complex during Get3 and Get4/5 binding.
As we reported previously, Get4/5 is able to precisely dis-
criminate between nucleotide states of Get3, enabling Get4/5
to regulate Get3 activity and prime it for efficient capture of the
TA substrate (22–24). The structure described here provides
evidence for an additional interaction dominated by electro-
static interactions and characterized by fast association rates.
This ultrafast diffusion-limited association of Get4/5 to Get3
(24) may function as an additional mechanism for Get4/5 to
select for the appropriate conformational state of Get3 or
inversely enables Get3 to constantly sample numerous Get4/5
until transfer of TA substrate occurs. Interestingly, this may
FIGURE 6.Get3binds toone-half of theGet4/5 heterotetramer.A, SEC-multiangle light scattering (MALS) analysis of theGet3Get4/5 complex (ScGet/3/4/5).
B, model depicting the N-ethylmaleimide (NEM) accessibility of a solvent-exposed Cys residue (S48C) on Get4/5 alone and in complex with Get3. C, results of
the alkylation assay shown in B. D, ATP-bound structure of Get3Get4/5N (Protein Data Bank code 4PWX) demonstrating the location of Q34C within the
Get3Get4/5 interface. E, results of the PEGylation assay with Get4 Q34C/5 alone or in complex with Get3. RIU, refractive index units. Sc, S. cerevisiae.
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also function to ensure that Get3 is quickly recruited following
dissociation from the membrane to prevent rebinding to Get1
or Get2 (24). This type of interaction has been seen in other
systems including barnase-barstar (41) and ribosome-interact-
ing proteins (42) and likely represents a recurring theme in
protein-protein interactions. This work provides further evi-
dence for the importance of Get4/5 in TA targeting.
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